Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities    
Net loss $ (339,197) $ (196,851)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 43,821 43,150
Use of restricted cash and cash equivalents for certain operating activities 59,942 78,972
Non-cash LNG inventory write-downs 23,505 27,851
Amortization of debt issuance costs and discount 10,971 8,591
Total (gains) losses on derivatives, net 89,286 (55,706)
Net cash from settlement of derivative instruments (19,834) 657
Loss on early extinguishment of debt 114,335 80,510
Other (6) 705
Changes in operating assets and liabilities:    
Accounts and interest receivable (19,653) (21,171)
Accounts receivable—affiliate 810 (1,614)
Accounts payable and accrued liabilities 46,693 38,655
Due to affiliates (813) 33,556
Deferred revenue (2,955) (2,955)
Advances to affiliate 656 (20,281)
LNG inventory (26,315) (33,248)
Other (3,721) (993)
Other—affiliate (147) 4,081
Net cash used in operating activities (22,622) (16,091)
Cash flows from investing activities    
Property, plant and equipment, net (1,968,249) (2,441,961)
Use of restricted cash and cash equivalents for the acquisition of property, plant and equipment 1,978,891 2,450,424
Purchase of Creole Trail Pipeline Business, net 0 (313,892)
Other (12,188) (17,648)
Net cash used in investing activities (1,546) (323,077)
Cash flows from financing activities    
Proceeds from issuances of long-term debt 2,584,500 3,504,478
Proceeds from sale of partnership common and general partner units 0 375,897
Contributions to Creole Trail Pipeline Business from Cheniere, net 0 20,896
Investment in restricted cash and cash equivalents (2,312,160) (3,202,888)
Debt issuance and deferred financing costs (94,270) (271,980)
Repayments of long-term debt (177,000) (100,000)
Distributions to owners (74,236) (66,632)
Other (1,050) 0
Net cash provided by (used in) financing activities (74,216) 259,771
Net decrease in cash and cash equivalents (98,384) (79,397)
Cash and cash equivalents—beginning of period 351,032 419,292
Cash and cash equivalents—end of period $ 252,648 $ 339,895